Imagion Biosystems Limited IBXXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 181.20K | 180.50K | 15.50K | 15.50K | 8.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 181.20K | 180.50K | 15.50K | 15.50K | 8.20K |
| Cost of Revenue | 547.50K | 545.40K | 489.30K | 487.80K | 195.90K |
| Gross Profit | -366.40K | -365.00K | -473.80K | -472.30K | -187.70K |
| SG&A Expenses | 233.30K | 232.40K | 299.40K | 298.40K | 179.80K |
| Depreciation & Amortization | 700.00 | 700.00 | 1.40K | 1.40K | 1.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 781.50K | 778.50K | 790.10K | 787.60K | 377.10K |
| Operating Income | -600.30K | -598.00K | -774.60K | -772.10K | -368.90K |
| Income Before Tax | -682.40K | -679.80K | -869.00K | -866.20K | -532.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -682.40K | -679.80K | -869.00K | -866.20K | -532.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -682.40K | -679.80K | -869.00K | -866.20K | -532.20K |
| EBIT | -600.30K | -598.00K | -774.60K | -772.10K | -368.90K |
| EBITDA | -599.70K | -597.30K | -773.10K | -770.70K | -367.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 490.47M | 490.47M | 353.60M | 353.60M | 201.34M |
| Average Diluted Shares Outstanding | 490.47M | 490.47M | 353.60M | 353.60M | 201.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |